Prophase Labs share price logo

Prophase Labs

OTC: PRPH

$0.02

+0.00

(+31.67%)

as on

Prophase Labs Stock Performance

as on October 3, 2026 at 6:49 am IST

  • Day's Low

    Day's High

    $0.01
    $0.02
    downward going graph

    36.71%

    Downside

    26.58%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.01
    $6.66
    downward going graph

    49.37%

    Downside

    42045.57%

    Upside

    downward going graph

Prophase Labs share price movements today

Previous Close
$0.01
Open
$0.01
Volume
45.1M
Market Cap
$286.3K
Day's Low - High
$0.01 - $0.02
52 Week Low - High
$0.01 - $6.66

Prophase Labs Historical Returns

1 Month Return
-21 %
3 Month Return
-79.74 %
1 Year Return
-99.72 %
3 Year Return
-99.96 %
5 Year Return
-99.97 %

Prophase Labs Stock Fundamentals & Key Indicators

Check Prophase Labs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$286.3K

EPS (TTM)

-3.12

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.95%

PE Ratio (TTM)

-0.01

Industry PE ratio

-4.20

PEG Ratio

0.00

EBITDA

-7.1M

Revenue (TTM)

3.2M

Profit Margin

16.38%

Return On Equity TTM

-1358.66%

Prophase Labs vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Prophase Labs with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Prophase Labs image
Prophase Labs
Buy$286.3K-99.97%-0.0116.38%0.00%
Idexx Laboratories image
Idexx Laboratories
Buy$40.9B-15.68%36.4062.45%0.00%
Thermo Fisher image
Thermo Fisher
StrongBuy$242.1B14.50%35.1741.03%0.28%
IQVIA Holdings image
IQVIA Holdings
StrongBuy$42.5B7.88%31.7626.23%0.00%
Agilent image
Agilent
StrongBuy$47.3B9.64%32.9653.73%0.49%
See all

Stock Returns calculator for Prophase Labs Stock including INR - Dollar returns

The Prophase Labs stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Prophase Labs investment value today

Current value as on today

₹306

Returns

-₹99,694

(-99.69%)

Returns from Prophase Labs Stock

-₹99,718 (-99.72%)

Dollar Impact

₹24 (+0.02%)

Analyst Recommendation on Prophase Labs Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Prophase Labs. Average target price of $13.8

Prophase Labs Share Price Target

Get share price movements and forecasts by analysts on Prophase Labs.

What analysts predicted

99.89%UPSIDE

Target Price

$13.8

Current Price

$0.0158

Analyzed by

7 Analysts

Target

$13.80

Prophase Labs target price $13.8, a slight upside of 99.89% compared to current price of $0.0158. According to 7 analysts rating.

Prophase Labs Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
8
3
3
2
3
1
1
0
0
1
Gross Profit
2
-3
0
0
0
0
0
0
0
0
Operating Income
-6
-11
-8
-7
-7
-3
-3
-4
-2
-2
EBITDA
-4
-9
-6
-6
-5
-2
-3
-4
-2
-1
Interest Expense
0
0
0
0
1
0
0
1
0
0
Depreciation
1
1
1
1
2
1
1
1
0
0
Income Before Tax
-6
-11
-8
-8
-9
-4
-3
-6
-3
-3
Income Tax Expense
-1
-2
-2
-2
-2
-
0
0
1
0
Net Income
-5
-8
-6
-6
-6
3
-4
-6
-5
-3
Net Profit Margin
27.82%
-87.34%
-11.92%
-19.24%
-5.24%
36.76%
58.86%
-13.93%
34.94%
22.35%

Prophase Labs Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Total Revenue
9
13
9
14
79
122
44
6
4
Gross Profit
1
4
2
4
32
70
16
0
1
Operating Income
-3
-1
-3
-3
9
23
-21
-38
-18
EBITDA
-3
-1
-2
-1
11
28
-14
-32
-11
Interest Expense
0
-
-
0
1
0
1
3
6
Depreciation
0
0
0
0
4
5
6
6
5
Income Before Tax
-3
-1
-3
-2
5
22
-22
-42
-23
Income Tax Expense
-17
0
-
0
0
4
-6
7
-
Net Income
41
-1
-3
-2
6
18
-16
-53
-14
Net Profit Margin
19.74%
36.42%
26.48%
31.73%
41.51%
57.61%
36.59%
-2.22%
31.85%

Prophase Labs Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-5
-8
-6
-6
-6
-4
-4
-6
-5
-2
Operating Cash Flow
-4
0
-5
-4
-4
-3
0
-21
0
0
Investing Cash Flow
0
-1
2
0
0
0
0
0
0
-
Financing Cash Flow
1
2
2
5
2
1
0
3
0
0
Change in Cash
-3
1
0
0
-1
0
0
0
0
0

Prophase Labs Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Net Income
41
-1
-3
-2
6
18
-16
-49
-23
Operating Cash Flow
-2
-2
0
-2
-13
28
-11
-17
-8
Investing Cash Flow
21
11
5
-1
-19
-2
-1
2
0
Financing Cash Flow
-16
-11
-5
9
35
-26
5
14
6
Change in Cash
2
-1
-1
6
1
0
-6
0
0

Global Institutional Holdings in Prophase Labs

Check out the Institutions with significant holdings in Prophase Labs.

Funds
Holdings
Perritt Funds Inc
0.11%
Victory Portfolios III
0.01%
Fidelity Concord Street Trust
0.00%

Insights on Prophase Labs

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Idexx Laboratories, Inc. has given 52.4% return, outperforming this stock by 152.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Idexx Laboratories, Inc. has given 59.7% return, outperforming this stock by 155.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.43M → 883.0K (in $), with an average decrease of 21.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PRPH stock has moved down by -37.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 3.96M → -6.83M (in $), with an average decrease of 132.8% per quarter

About Prophase Labs

ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.
OrganisationProphase Labs
Headquarters626 RXR Plaz, Uniondale, NY, 11556, US
IndustryMedical - Pharmaceuticals
CEOTed William Karkus

Key Management of Prophase Labs

Name

Title

Mr. Jason Karkus

President of Nebula Genomics

Mr. Kevin Quinn

Chief Product Officer of Nebula Genomics

Mr. Ted William Karkus

Chairman & CEO

FAQs

What is Prophase Labs share price today?

Prophase Labs share price today is $0.02 as on at the close of the market. Prophase Labs share today touched a day high of $0.02 and a low of $0.01.

What is the 52 week high and 52 week low for Prophase Labs share?

Prophase Labs share touched a 52 week high of $6.66 on and a 52 week low of $0.01 on . Prophase Labs stock price today i.e. is closed at $0.02,which is 99.76% down from its 52 week high and 97.50% up from its 52 week low.

What is Prophase Labs's market capitalisation today?

Prophase Labs market capitalisation is $0.00T as on .

How to invest in Prophase Labs Stock (PRPH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Prophase Labs on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Prophase Labs Stock (PRPH) from India?

Indian investors can start investing in Prophase Labs (PRPH) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Prophase Labs stock (as per the Rupee-Dollar exchange rate as on ). Based on Prophase Labs share’s latest price of $0.02 as on October 3, 2026 at 1:19 am IST, you will get 632.9114 shares of Prophase Labs. Learn more about fractional shares .

What are the returns that Prophase Labs has given to Indian investors in the last 5 years?

Prophase Labs stock has given -99.97% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?